www.praktickelekarenstvi.cz e15 PRAKTICKÉ LÉKÁRENSTVÍ AKTUÁLNÍ FARMAKOTERAPIE Močová retence jako vzácná komplikace užívání psychofarmak 10: 1289. 2. Crawford GB, Agar MM, Quinn SJ, et al. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium. Journal of palliative medicine. 2013; 16(11): 1335–1341. 3. Sahoo S. Aripiprazole in a patient susceptible to urinary side effects of antipsychotics. The Israel journal of psychiatry and related sciences 2007; 44(1): 74. 4. Benazzi F. Urinary retention with sertraline, haloperidol, and clonazepam combination. Can J Psychiatry 1998; 43: 1051–1052. 5. Ulmar G, Schunck H, Kober C. Urinary retention in the course of neuroleptic therapy with haloperidol. Pharmacopsychiatry 1998; 21(04): 208–209. 6. Hwang YJ, Dixon SN, Reiss JP, et al. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort stu‑ dy. Annals of internal medicine 2014; 161(4): 242–248. 7. Lin YT. Urinary retention as a rare adverse effect of clozapine: a case report. In Internati‑ onal Journal of Neuropsychofarmacology 2016; 19: 196–197. 8. Cohen R, Wilkins KM, Ostroff R, et al. Olanzapine and acute urinary retention in two ge‑ riatric patients. The American journal of geriatric pharmacotherapy 2007; 5(3): 241–246. 9. Sokolski KN, Brown BJ, Melden M. Urinary retention following repeated high-dose que‑ tiapine. Annals of Pharmacotherapy 2004; 38(5): 899–900. 10. Chung AK, Chua SE. Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone. Illin Psychopharmacol 2007; 27(5): 517–519. 11. KopečekM. Preskripce psychofarmak a jejich ceny v ČR v letech 2003, 2005 a 2008. Čes a slov psychiatr 2010; 106(2): 119–120. 12. Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepre‑ ssants: results of the German multicenter drug surveillance program AMSP. Pharmacopsy‑ chiatry 2004; 37(S1): 39–45. 13. Biederman J, Herzog DB, Rivinus TM, et al. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. Journal of clinical psychopharmacolo‑ gy 1985; 5(1): 10–16. 14. Güloğlu C, Orak M, Üstündağ M, et al. Analysis of amitriptyline overdose in emergen‑ cy medicine. Emergency Medicine Journal 2011; 28(4): 296–299. 15. Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Ame‑ rican family physician 2008; 77(5). 643–650. 16. Claghorn JL, Earl CQ, Walczak DD, et al. Fluvoxamine maleate in the treatment of de‑ pression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. Journal of clinical psychopharmacology 1996; 16(2): 113–120. 17. Yoshimura N, Chancellor MB. Neurophysiology of lower urinary tract function and dy‑ sfunction. Reviews in urology 2003; 5: 3. 18. Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepre‑ ssants: Results of the German multicenter drug surveillance program AMPS. Pharmacopsy‑ chiatry 2004; 37: 39–45. 19. Movig KLL, Leufkens HGM, Belitser SV, et al. Selective serotonin reuptake inhibitor-in‑ duced urinary incontinence. Pharmacoepidemiology and drug safety 2002; 11(4): 271–279. 20. Cannon TW, Chancellor MB. Pharmacotherapy for stress urinary incontinence. Rev Urol. 2003; 5: 135–141. 21. Viktrup L, Pangallo BA, Detke MJ, et al. Urinary side effects of duloxetine in the tre‑ atment of depression and stress urinary incontinence. Prim Care Companion J Clin Psy‑ chiatry 2004; 6: 65–73. 22. Çaksen H, Odabaş D. Urinary retention due to clonazepam in a child with dyskinetic cerebral palsy. Journal of Emergency Medicine 2004; 26(2): 244. 23. Steiner I, Birmanns B. Carbamazepine-induced urinary retention in long-standing dia‑ betes mellitus. Neurology 1993; 43(9): 1855–1855. 24. Filling-Katz MR, Merrick HF, Fink JK, et al. Carbamazepine in Fabry's disease: Effective analgesia with dose-dependent exacerbation of autonomic dysfunction. Neurology 1989; 39(4): 598–598. 25. Hmouda H, Salem CB, Grira M, et al. Carbamazepine-induced urinary retention. British journal of clinical pharmacology 2007; 64(6): 833. 26. Burger DH, Kappetein AP, Boutkan H, et al.. Prevention of urinary retention after gene‑ ral surgery: a controlled trial of carbachol/diazepam versus alfusozine. Journal of the Ame‑ rican College of Surgeons 1997; 185(3): 234–236.
RkJQdWJsaXNoZXIy NDA4Mjc=